Life Sciences Commercial Disputes

CRA’s life sciences arbitration support is grounded in a comprehensive insiders’ understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 25 years, we have consulted directly with major life science companies, law firms, and regulatory agencies around the globe. This deep industry knowledge is complemented by our extensive experience in complex litigation. CRA’s involvement has helped clients solve their most challenging strategic problems and resolve their most contentious disputes.

CRA assists clients in the evaluation of health and wellness claims (e.g., “all-natural”) for consumer products, including confectionery, beverage, and nutritional products. CRA experts have experience in evaluating methods in determining the value or price impact of specific product claims addressing liability and causation in the context of specific industry practices. Our experts have experience in working with various data sources to identify and analyze price impacts and in conducting surveys to evaluate consumer valuation of product claims.

CRA has experience evaluating product liability claims – including Lanham Act matters – for prescription drugs, over-the-counter products, medical devices, and other consumer goods. Our understanding of the industry’s complexity provides a basis for evaluating consumer theories of damages with a focus on understanding the link between marketing claims (or the lack of warnings) and product sales.